J Frontier CoTSE:2934 +2.49%68 EBITDA Margin % is 2.80% as of Nov. 2025, which is 16% below its 10-year median of 3.34. GuruFocus rates TSE:2934 with a GF Score™ of 68/100 and a GF Value™ of 円2,739.70 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 665 Healthcare Providers & Services companies, J Frontier Co ranks worse than 61.65% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. J Frontier Co's EBITDA for the
three
months ended in Nov. 2025 was 円159 Mil. J Frontier Co's Revenue for the
three
months ended in Nov. 2025 was 円5,675 Mil. Therefore, J Frontier Co's EBITDA margin for the quarter that ended in Nov. 2025 was 2.80%.
J Frontier Co (TSE:2934) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
J Frontier Co EBITDA Margin % Related Terms
J Frontier Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for J Frontier Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
J Frontier Co EBITDA Margin % Competitor Comparison
For the Pharmaceutical Retailers subindustry, J Frontier Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
J Frontier Co EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, J Frontier Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where J Frontier Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
J Frontier Co (TSE:2934) has a EBITDA Margin % of 2.80% as of Nov. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on J Frontier Co and its competitors. This is 16% below median its historical median of 3.34. According to the industry distribution chart, J Frontier Co ranks #410 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 61.7%.
Is J Frontier Co's EBITDA Margin % too high?
J Frontier Co's current EBITDA Margin % of 2.80% is 16% below median its 10-year median of 3.34. The Healthcare Providers & Services industry median EBITDA Margin % is 10.24. J Frontier Co's value of 2.80% is 72.7% below this industry median. Based on the distribution chart, J Frontier Co ranks #410 out of 665 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, J Frontier Co has a GF Score™ of 68/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does J Frontier Co's EBITDA Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, J Frontier Co ranks #410 out of 665 companies for EBITDA Margin %. This places J Frontier Co in the lower half of its industry. The industry median EBITDA Margin % is 10.24. J Frontier Co's value of 2.80% is 72.7% below this benchmark. While the company's 10-year median is 3.34 vs. the industry median of 10.24, J Frontier Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.24, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. J Frontier Co's current EBITDA Margin % of 2.80% is 72.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on J Frontier Co and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. J Frontier Co's current EBITDA Margin % is 2.80%, which is 16% below median its own 10-year median of 3.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is J Frontier Co stock overvalued right now?
Based on GuruFocus' analysis, J Frontier Co (TSE:2934) is currently considered Significantly Undervalued. The stock's GF Value™ is 円2,739.70, compared to a current price of 円1,564.00 — trading 42.9% below its estimated fair value. The current EBITDA Margin % is 2.80%, which is 16% below median its 10-year median of 3.34 and 72.7% below the Healthcare Providers & Services industry median of 10.24. J Frontier Co's overall GF Score™ is 68/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For J Frontier Co (TSE:2934), the current EBITDA Margin % is 2.80% as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is J Frontier Co (TSE:2934) Overvalued in 2026?
Based on GuruFocus' analysis, J Frontier Co stock appears to be undervalued.
The current stock price of 円1,564.00 is trading 42.9% below its estimated GF Value™ of 円2,739.70.
GuruFocus considers J Frontier Co to be Significantly Undervalued.
Key valuation signals for TSE:2934:
EBITDA Margin %: 2.80% (16% below median its 10-year median of 3.34)
GF Value™: 円2,739.70 vs. price of 円1,564.00 (42.9% below fair value)
Industry Position: 72.7% below the Healthcare Providers & Services median (#410 of 665)
No single metric tells the full story. See the TSE:2934 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2934 has been successfully added to your 
